v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 0 $ 18 $ 10,838 $ 47
Operating expenses        
Research and development 12,394 12,768 25,504 26,356
General and administrative 6,767 9,127 13,570 17,680
Total operating expenses 19,161 21,895 39,074 44,036
Operating loss (19,161) (21,877) (28,236) (43,989)
Other (expense) income:        
(Loss) gain from equity method investment 0 (665) 0 677
Loss on changes in other fair value adjustments (244) (2,464) (3,195) (2,415)
(Loss) gain on change in fair value of warrant liability (13,891) 753 (20,998) (51)
Interest expense (300) (358) (611) (712)
Interest income 943 1,116 1,942 2,439
Gain (loss) on disposal of assets 1 (25) 5 (34)
Total other expense (13,491) (1,643) (22,857) (96)
Net (loss) income $ (32,652) $ (23,520) $ (51,093) $ (44,085)
Net loss per share        
Basic (in USD per shares) $ (1.26) $ (2.13) $ (2.02) $ (4.33)
Diluted (in USD per shares) $ (1.26) $ (2.13) $ (2.02) $ (4.33)
Weighted-average shares of common stock outstanding        
Basic (in shares) 25,856,628 11,046,401 25,248,912 10,174,193
Diluted (in shares) 25,856,628 11,046,401 25,248,912 10,174,193
Share-based compensation expense $ 1,844 $ 2,937 $ 3,393 $ 5,758